Abstract:Importance: As many as 10% of women experience natural menopause by the age of 45 years. If confirmed, an increased risk of cardiovascular disease (CVD) and all-cause mortality associated with premature and early-onset menopause could be an important factor affecting risk of disease and mortality among middle-aged and older women. Objective: To systematically review and meta-analyze studies evaluating the effect of age at onset of menopause and duration since onset of menopause on intermediate CVD end points, CVD outcomes, and all-cause mortality. Data sources: Medical databases (ie, Medline, EMBASE, and Web of Science) until March 2015. Study selection: Studies (ie, observational cohort, case-control, or cross-sectional) that assessed age at onset of menopause and/or time since onset of menopause as exposures as well as risk of cardiovascular outcomes and intermediate CVD end points in perimenopausal, menopausal, or postmenopausal women. Data extraction and synthesis: Studies were sought if they were observational cohort, case-control, or cross-sectional studies; reported on age at onset of menopause and/or time since onset of menopause as exposures; and assessed associations with risk of CVD-related outcomes, all-cause mortality, or intermediate CVD end points. Data were extracted by 2 independent reviewers using a predesigned data collection form. The inverse-variance weighted method was used to combine relative risks to produce a pooled relative risk using random-effects models to allow for between-study heterogeneity. Main outcomes and measures: Cardiovascular disease outcomes (ie, composite CVD, fatal and nonfatal coronary heart disease [CHD], and overall stroke and stroke mortality), CVD mortality, all-cause mortality, and intermediate CVD end points. Results: Of the initially identified references, 32 studies were selected that included 310 329 nonoverlapping women. Outcomes were compared between women who experienced menopause younger than 45 years and women 45 years or older at onset; the relative risks (95% CIs) were 1.50 (1.28-1.76) for overall CHD, 1.11 (1.03-1.20) for fatal CHD, 1.23 (0.98-1.53) for overall stroke, 0.99 (0.92-1.07) for stroke mortality, 1.19 (1.08-1.31) for CVD mortality, and 1.12 (1.03-1.21) for all-cause mortality. Outcomes were also compared between women between 50 and 54 years at onset of menopause and women younger than 50 years at onset; there was a decreased risk of fatal CHD (relative risk, 0.87; 95% CI, 0.80-0.96) and no effect on stroke. Time since onset of menopause in relation to risk of developing intermediate cardiovascular traits or CVD outcomes was reported in 4 observational studies with inconsistent results. Conclusions and relevance: The findings of this review indicate a higher risk of CHD, CVD mortality, and overall mortality in women who experience premature or early-onset menopause.

Early menopause and premature ovarian insufficiency are associated with increased risk of type 2 diabetes: a systematic review and meta-analysis.

Metabolic Differences in Women with Premature Ovarian Insufficiency: a Systematic Review and Meta-Analysis

Association of age at menopause with type 2 diabetes mellitus in postmenopausal women in the United States: National Health and Nutrition Examination Survey 2011–2018

Early Menopause and Cardiovascular Disease Risk in Women With or Without Type 2 Diabetes: A Pooled Analysis of 9,374 Postmenopausal Women

Association between Reproductive Factors and Type 2 Diabetes: A Cross-Sectional Study

Is Early Menopause a Different Entity From Premature Ovarian Insufficiency?

Polycystic ovary syndrome and type 2 diabetes mellitus: A state-of-the-art review

Menopausal Hormone Therapy in Women with Type 2 Diabetes Mellitus: An Updated Review

Therapeutic strategies for type 2 diabetes mellitus in women after menopause

The risk of long-term cardiometabolic disease in women with premature or early menopause: A systematic review and meta-analysis

The Role of Sex Hormone Binding Globulin Levels in the Association of Surgical and Natural Premature Menopause with Incident Type 2 Diabetes

Menopausal Status, Age at Natural Menopause and Risk of Diabetes in China: a 10-Year Prospective Study of 300,000 Women

Age at menarche and the risk of gestational diabetes mellitus: a systematic review and meta-analysis

The effect of menopause on metabolic syndrome: cross-sectional results from the Canadian Longitudinal Study on Aging

Type 2 Diabetes Triples Risk of Early Menopause, Study Shows.

Gonadal dysfunction in women with diabetes mellitus

Level of hormones in menopause in relation to diabetic retinopathy among type 2 diabetic women

Optimising health after early menopause

Risk factors for natural menopause before the age of 45: evidence from two British population-based birth cohort studies

Association of Age at Onset of Menopause and Time Since Onset of Menopause With Cardiovascular Outcomes, Intermediate Vascular Traits, and All-Cause Mortality: A Systematic Review and Meta-analysis

Assessment of ovarian reserve in patients with type 1 diabetes: a systematic review and meta-analysis